Literature DB >> 16567468

Biochemical markers of acute pancreatitis.

W R Matull1, S P Pereira, J W O'Donohue.   

Abstract

Serum amylase remains the most commonly used biochemical marker for the diagnosis of acute pancreatitis, but its sensitivity can be reduced by late presentation, hypertriglyceridaemia, and chronic alcoholism. Urinary trypsinogen-2 is convenient, of comparable diagnostic accuracy, and provides greater (99%) negative predictive value. Early prediction of the severity of acute pancreatitis can be made by well validated scoring systems at 48 hours, but the novel serum markers procalcitonin and interleukin 6 allow earlier prediction (12 to 24 hours after admission). Serum alanine transaminase >150 IU/l and jaundice suggest a gallstone aetiology, requiring endoscopic retrograde cholangiopancreatography. For obscure aetiologies, serum calcium and triglycerides should be measured. Genetic polymorphisms may play an important role in "idiopathic" acute recurrent pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567468      PMCID: PMC1860356          DOI: 10.1136/jcp.2002.002923

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  52 in total

Review 1.  Value of genetic testing in the management of pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 2.  Laboratory diagnostic tests in acute pancreatitis.

Authors:  Joseph Smotkin; Scott Tenner
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

3.  Prognostic signs and the role of operative management in acute pancreatitis.

Authors:  J H Ranson; K M Rifkind; D F Roses; S D Fink; K Eng; F C Spencer
Journal:  Surg Gynecol Obstet       Date:  1974-07

4.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

5.  Prevalence of normal serum amylase levels in patients with acute alcoholic pancreatitis.

Authors:  S J Spechler; J W Dalton; A H Robbins; S G Gerzof; J S Stern; W C Johnson; D C Nabseth; E M Schimmel
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

6.  Acute pancreatitis and normoamylasemia. Not an uncommon combination.

Authors:  P A Clavien; J Robert; P Meyer; F Borst; H Hauser; F Herrmann; V Dunand; A Rohner
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

Review 7.  Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis.

Authors:  K Ayub; R Imada; J Slavin
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  The clinical value of the procalcitonin in prediction of severity and outcome in acute pancreatitis.

Authors:  D Pindak; V Parrak; J Pechan; A Vavrecka; L Kuzela; D Fuchs; J Irsakova
Journal:  Hepatogastroenterology       Date:  2003-12

9.  Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.

Authors:  C D Johnson; M Lempinen; C W Imrie; P Puolakkainen; E Kemppainen; R Carter; C McKay
Journal:  Br J Surg       Date:  2004-08       Impact factor: 6.939

10.  Prognostic factors in acute pancreatitis.

Authors:  S L Blamey; C W Imrie; J O'Neill; W H Gilmour; D C Carter
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

View more
  50 in total

1.  Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Authors:  Subhankar Chakraborty; Sukhwinder Kaur; Venkata Muddana; Neil Sharma; Uwe A Wittel; Georgios I Papachristou; David Whitcomb; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

2.  Limitations of transferability of absolute cut-points in non-standardised assays.

Authors:  Adie Viljoen; Patrick J Twomey
Journal:  J Clin Pathol       Date:  2007-05       Impact factor: 3.411

Review 3.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

4.  Diagnostic efficiency of amylase and type IV collagen in predicting chronic pancreatitis.

Authors:  Subir Kumar Das; Sowmya Varadhan; L Dhanya; Sukhes Mukherjee; S Mohana; V Balakrishnan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2009-05-08

5.  Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance.

Authors:  Manfred Hauben; Eric Y Hung
Journal:  Ther Adv Drug Saf       Date:  2016-05-23

Review 6.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

7.  Scolopendra subspinipes mutilans protected the cerulein-induced acute pancreatitis by inhibiting high-mobility group box protein-1.

Authors:  Il-Joo Jo; Gi-Sang Bae; Kyoung-Chel Park; Sun Bok Choi; Won-Seok Jung; Su-Young Jung; Jung-Hee Cho; Mee-Ok Choi; Ho-Joon Song; Sung-Joo Park
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  Chemopreventive effects of resveratrol in a rat model of cerulein-induced acute pancreatitis.

Authors:  Cristina Carrasco; María S Holguín-Arévalo; Gervasio Martín-Partido; Ana B Rodríguez; José A Pariente
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

9.  Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats.

Authors:  Ibrahim Akyazi; Evren Eraslan; Ahmet Gülçubuk; Elif Ergül Ekiz; Zeynep L Cırakli; Damla Haktanir; Deniz Aktaran Bala; Mete Ozkurt; Erdal Matur; Mukaddes Ozcan
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 10.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.